{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:34:46Z","timestamp":1649190886544},"reference-count":9,"publisher":"Societas Neurologica Japonica","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.634","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T23:11:22Z","timestamp":1376953882000},"page":"634-637","source":"Crossref","is-referenced-by-count":1,"title":["A case of systemic lupus erythematosus predominantly presenting with myositis at onset"],"prefix":"10.5692","volume":"53","author":[{"given":"Yoshinori","family":"Endo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Garton MJ, Isenberg DA. Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases. Br J Rheumatol 1997;36:1067-1074.","DOI":"10.1093\/rheumatology\/36.10.1067"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Foote RA, Kimbrough SM, Stevens JC. Lupus myositis. Muscle Nerve 1982;5:65-68.","DOI":"10.1002\/mus.880050112"},{"key":"3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Dayal NA, Isenberg DA. SLE\/myositis overlap: are the manifestations of SLE different in overlap disease? Lupus 2002;11:293-298.","DOI":"10.1191\/0961203302lu186oa"},{"key":"5"},{"key":"6","unstructured":"6) Isenber DA, Snaith ML. Muscle Disease in systemic lupus erythematosus: a study of its nature, frequency and cause. J Rheumatol 1981;8:917-924."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 2012;64:797-808.","DOI":"10.1002\/acr.21664"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Szeto CC, Kwan BC, Lai FM, et al. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. Rheumatology (Oxford) 2008;47:1678-1681.","DOI":"10.1093\/rheumatology\/ken335"},{"key":"9","unstructured":"9) Uchino A, Tsukamoto H, Nakashima H, et al. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria. Clin Exp Rheumatol 2010;28:6-12."}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u7b4b\u708e\u304c\u767a\u75c7\u6642\u3088\u308a\u524d\u666f\u306b\u7acb\u3063\u305f\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T18:03:52Z","timestamp":1498068232000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/53.634?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.634","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}